Pelthos Therapeutics PTHS

NYSE PTHS

$22.71 -0.71 (-3.03%)

As of: Sep 10, 2026 · 10:59 AM EDT

Pelthos Therapeutics (PTHS) Operating Margin (QoQ) (2025 - 2026)

Analysis

Pelthos Therapeutics (PTHS) Operating Margin (QoQ) (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Johnson & Johnson	641.30 Bn	620.54 Bn	17.26 Bn
2	AbbVie	446.34 Bn	439.77 Bn	12.70 Bn
3	Merck	357.25 Bn	350.11 Bn	12.21 Bn
4	Novartis Ag	268.57 Bn	260.88 Bn	11.24 Bn
5	Pfizer	156.47 Bn	144.77 Bn	10.94 Bn
6	Sanofi	52.23 Bn	44.85 Bn	10.79 Bn
7	Revolution Medicines	43.14 Bn	43.14 Bn	-
8	Incyte	24.83 Bn	20.29 Bn	1.57 Bn
9	United Therapeutics	21.31 Bn	18.64 Bn	683.80 Mn
10	Pelthos Therapeutics	80.38 Mn	55.82 Mn	21.23 Mn

Historic Data

Historic Data

Download Data

Date	Value
Jun 30, 2026	529.00
Mar 31, 2026	1,198.00
Dec 31, 2025	7,544.00

Pelthos Therapeutics

NYSE: PTHS

$22.71 ▼ -0.71 (-3.03%)

Sep 10, 2026 · 10:59 AM EDT